You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Raclopride

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroimaging Studies of Reward Processing in Depression

Completed
  • Major Depressive Disorder
  • PET Scan with Raclopride
  • Belmont, Massachusetts
    David Crowley
Feb 1, 2023

Traumatic Brain Injury Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (tDCS, [11C] Raclopride)

Recruiting
  • Traumatic Brain Injury
  • tDCS
  • [11C] Raclopride
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Obesity, Healthy Volunteers, Overweight Trial run by the NIDDK ([c11] raclopride, [18F]fallypride)

Active, not recruiting
  • Obesity
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2022

Diabetes, Type 2 Trial in Tuebingen (intranasal insulin, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • intranasal insulin
  • Placebo
  • Tuebingen, Germany
    University of Tuebingen, Department of Internal Medicine IV
Jun 24, 2021

Depression, Psychosis, Anhedonia Trial in Chapel Hill (Transdermal Estradiol, Micronized Progesterone, Matching Placebo Patch)

Recruiting
  • Depression
  • +2 more
  • Transdermal Estradiol
  • +3 more
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Dec 20, 2022

Cocaine Dependence Trial in New Haven (Methylphenidate, Alpha Methyl Para Tyrosine (AMPT), [11C]PHNO)

Terminated
Has Results
  • Cocaine Dependence
  • New Haven, Connecticut
    Connecticut Mental Health Center
Feb 24, 2021

Eating Disorder Trial in San Diego ([11C]raclopride, [11C]DASB, amphetamine)

Completed
Has Results
  • Eating Disorder
  • San Diego, California
    University of California San Diego
Apr 7, 2020

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

Withdrawn
  • Schizophrenia
  • NPA radiotracer
  • +2 more
  • New York, New York
    NYU Langone Health
May 27, 2020

Obesity Trial (standardized liquid mixed meal Nutridrink®)

Not yet recruiting
  • Obesity
  • standardized liquid mixed meal Nutridrink®
  • (no location specified)
Nov 1, 2022

Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain

Suspended
  • Cocaine Abuse
  • Brain Dopamine Reactivity
  • Brain Dopamine Receptor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Smoking, Cannabis Trial in New Haven (cannabis)

Recruiting
  • Smoking
  • Cannabis
  • New Haven, Connecticut
  • +2 more
Dec 6, 2022

Normal Physiology Trial run by the NIAAA (Oral Methylphenidate followed by IV , Oral followed by IV Methylphenidate, Oral

Enrolling by invitation
  • Normal Physiology
  • Oral Methylphenidate followed by IV placebo
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Narcolepsy With Cataplexy, Healthy Controls Trial in Toronto (Xyrem)

Completed
Has Results
  • Narcolepsy With Cataplexy
  • Healthy Controls
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health (CAMH)
Feb 26, 2021

Schizophrenia Trial in Saint Louis (LB-102)

Completed
  • Schizophrenia
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 28, 2022

Alzheimer, Apathy in Dementia Trial (Intermittent Theta Burst Stimulation (iTBS))

Not yet recruiting
  • Alzheimer Disease
  • Apathy in Dementia
  • Intermittent Theta Burst Stimulation (iTBS)
  • (no location specified)
May 20, 2022

MDD Trial in Tübingen (Ghrelin, Placebo)

Recruiting
  • Major Depressive Disorder
  • Tübingen, BW, Germany
    Department of Psychiatry & Psychotherapy, University of Tübingen
Apr 7, 2022

Opioid-Related Disorders Trial in Morgantown (Deep Brain Simulator)

Active, not recruiting
  • Opioid-Related Disorders
  • Deep Brain Simulator
  • Morgantown, West Virginia
    West Virginia University Rockefeller Neuroscience Institute
Aug 17, 2022

Stress Response Trial (tDCS actif, tDCS Sham)

Not yet recruiting
  • Stress Response
  • tDCS actif
  • tDCS Sham
  • (no location specified)
Apr 20, 2023

Levodopa-induced Dyskinesia, Parkinson's Disease Trial in Bunkyo (DSP-9632P 27.5 mg, DSP-9632P 82.5 mg, Placebo)

Recruiting
  • Levodopa-induced Dyskinesia
  • Parkinson's Disease
  • DSP-9632P 27.5 mg
  • +4 more
  • Bunkyo, Tokyo, Japan
    Nippon Medical School Hospital
Jun 23, 2022

Polymorphism-Genetic, Pain, Addiction Trial run by the NIAAA (Morphine, Placebo)

Completed
Has Results
  • Polymorphism-Genetic
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2021

Somatotopy in Parkinson's Disease

Recruiting
  • Parkinson Disease
  • PET/MR Imaging
  • Vancouver, British Columbia, Canada
    Monica Yenko
May 3, 2021

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)

Completed
  • Schizophrenia
  • +4 more
  • Risperidone/Olanzapine and PET scans
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Jun 2, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (risperidone)

Unknown status
  • Schizophrenia
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 6, 2020

Heroin Addiction, Relapse Trial in Xi'an (Repetitive transcranial magnetic stimulation)

Unknown status
  • Heroin Addiction
  • Relapse
  • Repetitive transcranial magnetic stimulation
  • Xi'an, Shaanxi, China
    Tangdu Hospital
Jan 20, 2021

Cognition Disorder, Attention Deficit Disorder, Traumatic Brain Injury Trial run by the (Methylphenidate)

Completed
Has Results
  • Cognition Disorder
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 13, 2019